Corium International, Inc.

 Company Summary: Transaction Overview: Significance of the Transaction:
  • The Notes financing permits the Company to expand its specialty contract manufacturing capabilities and broaden existing strategic partnerships with global generics manufacturers
  • The IPO allows the Company to pursue advanced clinical development of its proprietary CorPlex and MicroCor transdermal product candidates, in addition to providing attractive liquidity to shareholders
Healthios Role:
  • Healthios served as strategic adviser to Corium on the Notes and IPO transactions
  • This transaction highlights Healthios commitment to capital formation for emerging growth companies, our success in completing complex transaction, and our dedication to deep, long-term relationships.